These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27756693)

  • 41. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease.
    Costa A; Peppe A; Dell'Agnello G; Carlesimo GA; Murri L; Bonuccelli U; Caltagirone C
    Dement Geriatr Cogn Disord; 2003; 15(2):55-66. PubMed ID: 12566593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
    Negrotti A; Secchi C; Gentilucci M
    Neuropsychologia; 2005; 43(3):450-9. PubMed ID: 15707620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Semantic activation in Parkinson's disease patients on and off levodopa.
    Angwin AJ; Arnott WL; Copland DA; Haire MP; Murdoch BE; Silburn PA; Chenery HJ
    Cortex; 2009 Sep; 45(8):950-9. PubMed ID: 19356748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
    Gotham AM; Brown RG; Marsden CD
    Brain; 1988 Apr; 111 ( Pt 2)():299-321. PubMed ID: 3378138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motor deficits in Parkinsonian reaching: dopa-sensitivity influenced by real-world task constraint.
    Doan J; Whishaw IQ; Pellis SM; Suchowersky O; Brown LA
    J Mot Behav; 2006 Jan; 38(1):45-59. PubMed ID: 16436362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task.
    Waldthaler J; Stock L; Krüger-Zechlin C; Timmermann L
    Neuropsychologia; 2021 Dec; 163():108082. PubMed ID: 34728241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS; Lou JS; Eaton R; Nutt J
    Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease.
    Perrotta A; Serrao M; Bartolo M; Valletta L; Locuratolo N; Pujia F; Fattapposta F; Bramanti P; Amabile GA; Pierelli F; Parisi L
    Clin Neurophysiol; 2005 Sep; 116(9):2091-8. PubMed ID: 16029959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease.
    Seemiller J; Morrow C; Hinkle JT; Perepezko K; Kamath V; Pontone GM; Mills KA
    Mov Disord Clin Pract; 2024 May; 11(5):534-542. PubMed ID: 38470011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease.
    Rahimi F; Bee C; Duval C; Boissy P; Edwards R; Jog M;
    J Parkinsons Dis; 2014; 4(4):617-27. PubMed ID: 25055960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease.
    Tremblay PL; Bedard MA; Langlois D; Blanchet PJ; Lemay M; Parent M
    Exp Brain Res; 2010 Sep; 205(3):375-85. PubMed ID: 20680249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine treatment and cognitive functioning in individuals with Parkinson's disease: the "cognitive flexibility" hypothesis seems to work.
    Costa A; Peppe A; Mazzù I; Longarzo M; Caltagirone C; Carlesimo GA
    Behav Neurol; 2014; 2014():260896. PubMed ID: 24825952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
    Mongeon D; Blanchet P; Messier J
    Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy.
    Marini P; Ramat S; Ginestroni A; Paganini M
    Neurol Sci; 2003 Oct; 24(3):184-5. PubMed ID: 14598078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dopaminergic therapy on locomotor adaptation and adaptive learning in persons with Parkinson's disease.
    Roemmich RT; Hack N; Akbar U; Hass CJ
    Behav Brain Res; 2014 Jul; 268():31-9. PubMed ID: 24698798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease.
    Relja M; Klepac N
    J Neurol Sci; 2006 Oct; 248(1-2):251-4. PubMed ID: 16797593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.